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Abstract
Background: terminal deletions of the distal portion of the short arm of chromosome 3 cause a rare contiguous
gene disorder characterized by growth retardation, developmental delay, mental retardation, dysmorphisms,
microcephaly and ptosis. The phenotype of individuals with deletions varies from normal to severe. It was
suggested that a 1,5 Mb minimal terminal deletion including the two genes CRBN and CNTN4 is sufficient to cause
the syndrome.
In addition the CHL1 gene, mapping at 3p26.3 distally to CRBN and CNTN4, was proposed as candidate gene for a
non specific mental retardation because of its high level of expression in the brain.
Methods and Results: we describe two affected siblings in which array-CGH analysis disclosed an identical
discontinuous terminal 3p26.3 deletion spanning less than 1 Mb. The deletion was transmitted from their normal
father and included only the CHL1 gene. The two brothers present microcephaly, light mental retardation, learning
and language difficulties but not the typical phenotype manifestations described in 3p- syndrome.
Conclusion: a terminal 3p26.3 deletion including only the CHL1 gene is a very rare finding previously reported
only in one family. The phenotype of the affected individuals in the two families is very similar and the deletion
has been inherited from an apparently normal parent. As already described for others recurrent syndromes with
variable phenotype, these findings are challenging in genetic counselling because of an evident variable
penetrance.
Introduction
The 3p deletion syndrome is a rare contiguous gene
syndrome caused by deletions in the 3p25-pter region.
The deletions are variable in size, ranging from one to
several megabases, they don’t present common break-
points and mostly occur de novo, but a few familial
cases have been reported [1-4]. The syndrome is charac-
terized by a recognizable phenotype including low birth
weight, growth and mental retardation, developmental
delay and characteristic facial appearances. The clinical
manifestations in individuals with 3p deletions vary
from normal to severe. A milder phenotypic effect or a
normal intelligence [4,5] has also been described for
larger [3,6], often inherited, deletions of this region
[1-4,7,8] and appears to be secondary to the breakpoint’s
location and the deletion extent [1-3]. Moreover, cases
with minimal pathological features despite the presence
of a large terminal 3p deletion have been described
[3,4,9].
Recently, a cohort of 14 patients with visible distal 3p
deletions has been studied by SNP array to better define
the genetic basis of 3p deletion syndrome [10]. Among
the different haploinsufficient genes, CRBN and CNTN4
have been indicated as sufficient to cause the typical
clinical features [9] while the CHL1 gene has been sug-
gested to contribute to mental development [4,8,11].
We describe a sub microscopic 3p26.3 terminal dele-
tion transmitted from the normal father to his two
affected children. The imbalance is less than 1 Mb in
size and includes only the gene CHL1, a member of the
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gested to be responsible for mental defects in patients
with 3p- syndrome.
Methods
Karyotyping was performed on peripheral blood of the
patients and their parents. Screening by Multiplex-liga-
tion-dependent probe amplification method (MLPA) (kit
S A L S AP 0 3 6 - E 1 ,M R CH O L L A N D ,A m s t e r d a m ,T h e
Netherlands) was used for subtelomeric analysis and
fluorescent in situ hybridization (FISH) analysis (ToTel
Vysion kit, Vysis, Abbott Molecular, Illinois, U.S.A.) was
subsequently used as confirmation method.
To further characterize the rearrangement extent and
breakpoints an array-CGH using the Human CGH
Microarray Kit 400 K (Agilent Technologies, Palo Alto,
CA, USA) covering the whole genome with a 5.3 Kb
overall median probe spacing was performed following
the manufacturer’s protocol.
Case report
The patient is the first child of healthy, non-consangui-
neous parents. Karyotype was normal male. No family
history of congenital anomalies or mental retardation
was referred. The child was born after 36 weeks of
uneventful pregnancy, by caesarean section. At birth,
weight was 2.400 kg (10th-25th centile); length and head
circumference were not reported. Apgar score was 9 at
first minute. He showed a regular physical and psycho-
motor development (sitting at 6 months, walking at 14
months). At school learning difficulties were observed
and a neuropsychological evaluation was performed. A
borderline I.Q. level, measured with Wechsler Intelli-
gence Scale for Children-Revised (WISC-R), associated
with a deficit in graphic test of Perceptual Organization
(Bender-Santucci test) and language disorders with pho-
nological impairment, dyslexia and dyscalculia were
noticed.
At the age of 8 years dropping off to sleep an episode
of tonic clonic seizures at right hemi-body occurred for
which he was hospitalized.
At physical examination (9 years), weight was 26 kg
(50th centile), height 123 cm (10th -25th centile), head
circumference 55 cm (>50th centile). In addition epi-
chantal folds, joint hyperlaxity and three abdominal
cafè-au-lait spots were noticed. Ophthalmologic evalua-
tion showed divergent strabismus at the right eye, myo-
pia and retinal spots without clinical significance.
Cerebral MRI identified mild ectopia of cerebellar ton-
silla at the foramen magnum. Abdominal ultrasound
examination, cardiological examination and auditory
evoked potentials were normal. Electroencephalogram
showed aspecific anomalies. At the age of nine years a
second episode similar to the precedent (characterized
by tonic-clonic seizure at right hemi-body at dropping
off to sleep) occurred causing a post-ictal paresis at
right hemi-body during 10 minutes. The EEG showed
centrotemporal spikes in the left hemisphere, activated
by sleep and a treatment with OXC was started.
The brother was born after 36 weeks of uneventful
pregnancy, by caesarean section. At birth, weight was
2.080 kg (3rd -10th centile), length 44 cm (3rd -10th
centile), head circumference 31.5 cm (10th centile).
Apgar score was 7 and 9 at first and fifth minute,
respectively. As an infant he presented a regular psycho-
motor development with a delayed language for which
he needed a school support.
At 4 years and 6 months the neuropsychological eva-
luation revealed normal non-verbal performances at psy-
chometric test but difficulties in both expressive and
comprehensive languages, with lexical and syntactic
impairment. On examination (7 years), weight was 26 kg
(75th centile), height 122 cm (50th centile) and head cir-
cumference 52.5 cm (>50th centile). At physical exami-
nation he presented straight eyebrows, short and
smooth philtrum, right single palmar crease, shallow
scrotum, one cafè-au-lait spot at the back, dry skin.
Abdominal ultrasound examination, cardiological and
ophthalmologic evaluation, electroencephalogram and
auditory evoked potentials were normal. Laboratory
investigations for metabolic disorders and molecular
analysis for fragile-X syndrome were negative.
The father has completed his studies as a dentist, he
doesn’t present any physical impairment and has been
considered healthy and normal all his life.
Karyotype of the two brothers and their parents were
normal. Diagnosis was done after multiplex-ligation
probe amplification (MLPA) analysis of subtelomeric
regions. A deletion of the probe 1721-L01329 (CHL1)i n
both sibs and their father was identified and subsequently
confirmed by FISH analysis using the commercial probe
TelVysion 3p (Vysis) containing the marker D3S4559
corresponding to the CHL1 gene and mapping on the
short arm of chromosome 3 (Figure 1A). Array compara-
tive genomic hybridization (aCGH) analysis of the three
individuals showed an identical terminal deletion (Figure
1B). The 3p26.3 region was deleted for the distal ~555.4
Kb (Figure 1B), from oligomer A_18_P14035586 (62,075
Kb) (first deleted) to oligomer A_18_P14033572 (617,474
Kb) (last deleted), containing only the RefSeq gene CHL1.
A subsequent non-deleted region was observed from oli-
gomer A_16_P16103673 (626,187 Kb) to oligomer
A_16_P36141085 (726,704 Kb) and a second deleted seg-
ment was identified for the proximal ~199 Kb from oli-
gomer A_16_P16103981(758905 Kb) to oligomer
A_16_P16104360 (957743 Kb). No Refseq genes are pre-
sent within this region. Overall the three regions are only
partially overlapping with numerous small putative
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Database of Genomic Variants (http://projects.tcag.ca/
variation, build 37.1, Feb 2009). In addition they are
mostly represented by duplications and no individuals
with CHL1 deletions are described (Figure 1C).
Additionally, a few CNVs, spanning from 103.5 to 696
Kbs, have been identified along the genome in the two
brothers and their parents (Table 1). Among them, a
maternally inherited 1q44 duplication of 696 Kbs is
shared by the two brothers and absent in the father.
Figure 1 FISH and array CGH results. A) FISH with telomeric probes specific for the 3qter (red signals) and 3pter (green signal) regions. The
arrow shows the absence of signal on the short arm of a chromosome 3. B) Array-CGH graphical overview of the 3p26.3 non contiguous
terminal deletion. The region is deleted for the distal ~555.4 Kb from 62,075 Kb (A_18_P14035586) to 617,474 Kb (A_18_P14033572) and for the
proximal ~199 kb from 758,905 Kb (A_16_P16103981) to 957,743 Kb (A_16_P16104360). Arrows indicate the non-deleted segment which spans
from 626,187 Kb (A_16_P16103673) to 726,704 Kb (A_16_P36141085). From the left, the profiles refer to: first child, second child, normal mother
and father. C) Custom image from UCSC Genome Browser showing an overview of the Refseq genes and CNVs content in the proximally
deleted, normal and distally deleted regions.
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The 3p deletion syndrome is a rare contiguous gene
syndrome caused by 3p25-pter deletions variable in
size and mostly occurring de novo. The phenotype is
recognizable and varies from normal to severe. Here,
we describe a family with two affected children pre-
senting a submicroscopic 3p26.3 non-contiguous term-
inal deletion inherited from the normal father. Overall
the region spans less than 1 megabase and includes
only one Refseq gene named CHL1 which has been
previously proposed as responsible for cognitive
impairment in individuals with 3p terminal deletions
[8,11]. The two brothers have a mild mental retarda-
tion characterized by learning and language difficulties,
but not the distinct features usually described in asso-
ciation with the 3p deletion syndrome. A 1,5 Mb mini-
mal critical region including two genes, CRBN and
CNTN4, has been suggested to play a causative role in
the aetiology of 3p- syndrome (Figure 2). Moreover,
loss of CHL1 was proposed to play an additional role
on the cognitive impairment of the affected individuals
[8]. At our knowledge, only one similar case has been
reported [4]. The authors describe a terminal 3p dele-
tion of 1.1 Mb including only the CHL1 locus and
transmitted from the normal mother to her affected
son. The index patient presents facial features different
from those previously reported in the 3p deletion syn-
drome and skin pigmentation, an unspecific feature
not related to this syndrome. Interestingly, mild learn-
ing difficulties and severe disability in language were
observed. The CHL1 gene encodes for a member of
the L1 family of neural cell adhesion molecules. These
proteins play an important role in the building and
functioning of the brain because a lot of events, like
migration and synaptogenesis, require cell to cell and
cell to matrix interactions.
CHL1 has been mapped to 3p26.3, and was proposed
as a candidate gene for non specific mental retardation
because it is highly expressed in the brain [4,8,12-14].
The finding of a balanced translocation disrupting the
Table 1 List of the additional copy number variations (CNVs) identified in the family.
Case CNV’s coordinates Size (Kbs) Gain/Loss Parental origin Presence in DGV*
Patient Chr1:246,713,074-247,409,060 696 Gain maternal partially
Chr2: 89,135,619-89,534,147 398.5 Loss maternal yes
Brother Chr1:246,713,074-247,409,060 696 Gain maternal partially
Chr2: 89,135,619-89,312,590 177 Loss paternal yes
Father Chr2: 246,713,074-89,312,590 177 Loss unknown yes
Mother Chr1:16,927,124-17,253,438 326.3 Gain unknown yes
Chr1:104,107,589-104,211,056 103.5 Gain unknown yes
Chr1:246,713,074-247,409,060 696 Gain unknown partially
Chr2: 89,135,619-89,534,147 398.5 Loss unknown yes
Chr4:160,294,949-160,578,715 283.8 Loss unknown no
* Database of Genomic Variants (http://projects.tcag.ca/variation, build 37.1, Feb 2009).
Figure 2 Schematic representation of the previously reported 3p deletions analyzed by aCGH for which the extension of the deleted
segment was reported. The black lines below the chromosomal 3p 26.3p25.3 region indicate the deletions whose references and extensions
are indicated on the right.
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mental retardation further supports this suggestion [11].
Our findings strongly confirm the evidence that a loss
of the more proximal genes is required to cause the
typical 3p- syndrome clinical features, moreover the pre-
sence of a small terminal 3p deletion including only the
CHL1 gene can determine only a mild phenotype or no
symptoms at all as we observed in the members of our
family.
Since the introduction of array-CGH analysis the find-
ing of a transmitted chromosomal variant from a pheno-
typically normal parent has became more frequent.
Inherited CNVs associated with both abnormal and nor-
mal phenotype have been recently reviewed in 200
families[13]. Thrombocytopenia-Absent Radius syn-
drome [15], del(1)(q21.1)[16] and deletions and duplica-
tions of 16p13.11 region[17] represent only a few
examples of genetic variations transmitted from an
apparently normal parent to an affected child. A bias of
ascertainment, chromosomal non-penetrance and gene
modification are hypothesized as possible explanations
[6]. Moreover an apparently unaffected parent who car-
ries the deletion could also have subtle phenotypic fea-
tures consistent with the deletion that would become
evident on further clinical evaluation. Other possibilities
may account for phenotypic variability including differ-
ences in genetic background, epigenetic phenomena,
expression or regulatory variation, and the unmasking of
recessive variants residing on the other allele. Disease
type and severity may be explained by the occurrence of
additional rare events and their inheritance within
families. The combination of two large CNVs in a single
individual would increase or decrease the dosage for dif-
ferent genes creating a sensitized genomic background
[18].
The “two-hit” model, as proposed by Girirajan et al
[19], wherein a secondary rearrangement event is neces-
sary to show the phenotype, could be an alternative
explanation for the differences between the father and
his sons.
We documented, in fact, the two affected individuals
had an additional chromosomal abnormality larger than
500 Kbp and affecting the 1q44 region (Table 1). We
can speculate this maternally inherited duplication,
which is neutral in the mother, could instead contribute
to the differences in the disease outcome observed
between the two siblings and their father.
In conclusion, this familial case, characterized by a
transmitted 3p deletion containing only the CHL1 gene
and associated with a strong phenotypic variability, con-
firms the hypothesis that the association of terminal 3p
deletion, mental retardation and learning disabilities is
not casual.
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